In the fall of 2018, EPA finalized tailored and streamlined standards for managing hazardous waste pharmaceuticals that reduce the cost and compliance burden for the healthcare sector, while ensuring the safe management of hazardous waste pharmaceuticals. These changes provide regulatory certainty and national consistency on how the Resource Conservation and Recovery Act (RCRA) applies to the reverse distribution of prescription pharmaceuticals while incorporating flexibilities to accommodate current business practices. With this rule EPA is also taking a common-sense regulatory approach to the disposal of Food and Drug Administration (FDA)-approved, over-the-counter nicotine replacement therapies (i.e., patches, gums and lozenges), which will no longer be considered hazardous waste when discarded.
If you click on the link above and the target URL does not connect to a U.S. Federal website (i.e. does not send you to a .gov or .mil address), the following disclaimer applies:
Links to any non-Federal organizations are provided solely as a service to our users. These links do not constitute an endorsement of these organizations or their programs by FedCenter.gov or the Federal Government, and none should be inferred. Any reference to a commercial product, process, service, or company is not an endorsement or recommendation by the U.S. government, FedCenter, or any of its partners. FedCenter.gov is not responsible for the content of the individual organization Web pages found at these links.